RO5459072

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RO5459072, covering 2017-08-25 to 2018-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome [Phase 2]